Invesco Pharmaceuticals ETF Rating $86.54 -0.33 (-0.38%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.72Holdings in PJP have an aggregate rating of Moderate Buy based on 382 analyst ratings issued in the past year covering 30 companies (99.9% of the portfolio).PJP Aggregate Price Target$86.54High Prediction$86.54Average Prediction$86.54Low Prediction$86.54Holdings in PJP have an aggregate price target of $86.54 and a range of $86.54 to $86.54 covering 30 companies (99.9% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.67%LLYEli Lilly and Company$874.12+0.1%4.8481 of 5 stars2.85$1,007.94 15.3%20Positive News5.54%ABBVAbbVie$202.03+0.6%4.6504 of 5 stars2.88$208.35 3.1%24Dividend AnnouncementAnalyst RevisionPositive News5.50%ABTAbbott Laboratories$135.04+1.4%4.8956 of 5 stars2.83$133.06 -1.5%18Dividend AnnouncementPositive News4.98%AMGNAmgen$303.01+1.7%4.4634 of 5 stars2.46$314.09 3.7%24Insider TradePositive News4.97%JNJJohnson & Johnson$162.35+1.7%4.5432 of 5 stars2.56$170.67 5.1%18Ex-DividendAnalyst ForecastOptions VolumePositive News4.88%PFEPfizer$26.32+1.6%4.9993 of 5 stars2.50$31.92 21.3%16Options VolumePositive News4.63%BMYBristol-Myers Squibb$55.85+0.1%4.5925 of 5 stars2.30$57.86 3.6%20Analyst RevisionPositive News4.11%MRKMerck & Co., Inc.$89.40+2.0%5 of 5 stars2.58$116.39 30.2%24Analyst DowngradeOptions Volume3.98%LQDALiquidia$16.11-2.4%2.0541 of 5 stars3.11$25.38 57.5%93.40%TVTXTravere Therapeutics$21.98-6.8%2.955 of 5 stars2.93$27.77 26.3%14Earnings ReportAnalyst ForecastNews CoverageGap Down3.35%CORTCorcept Therapeutics$63.54-2.4%4.7297 of 5 stars3.00$88.25 38.9%5Upcoming Earnings3.17%GILDGilead Sciences$109.95-0.1%4.7853 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News3.07%HRMYHarmony Biosciences$34.56-0.9%4.731 of 5 stars3.00$53.67 55.3%9Analyst ForecastAnalyst RevisionNews Coverage3.00%SUPNSupernus Pharmaceuticals$33.05-4.5%1.6129 of 5 stars2.33$36.00 8.9%3Analyst DowngradeNews Coverage2.97%JAZZJazz Pharmaceuticals$136.01-0.5%4.9569 of 5 stars2.93$180.33 32.6%15Upcoming EarningsNews Coverage2.87%TARSTarsus Pharmaceuticals$47.84-1.8%1.1673 of 5 stars3.00$56.00 17.1%7Gap Up2.76%UTHRUnited Therapeutics$361.10-1.7%4.3677 of 5 stars2.67$388.25 7.5%12Insider TradePositive News2.74%PBHPrestige Consumer Healthcare$84.66-0.1%4.1695 of 5 stars2.60$92.60 9.4%5Positive News2.73%ANIPANI Pharmaceuticals$57.94-2.9%4.3784 of 5 stars3.00$77.71 34.1%82.71%LGNDLigand Pharmaceuticals$120.56-1.2%4.1424 of 5 stars3.00$147.00 21.9%6Positive News2.63%COLLCollegium Pharmaceutical$29.13-2.1%3.9883 of 5 stars2.80$43.60 49.7%5News Coverage2.56%INVAInnoviva$18.08+0.1%2.7143 of 5 stars3.001Analyst DowngradeNews CoveragePositive News2.53%AMRXAmneal Pharmaceuticals$7.83-0.5%3.7675 of 5 stars2.80$10.00 27.7%5Positive News2.47%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement2.35%BIIBBiogen$140.64+2.6%4.7395 of 5 stars2.43$211.85 50.6%30Analyst Forecast2.32%PRGOPerrigo$25.37+0.5%4.9672 of 5 stars2.40$35.00 38.0%5Dividend IncreaseAnalyst DowngradeNews Coverage2.22%VTRSViatris$11.25+1.7%2.0155 of 5 stars2.00$13.67 21.5%3News Coverage2.16%OCULOcular Therapeutix$7.00-3.4%3.3993 of 5 stars2.83$17.00 142.9%61.88%AMPHAmphastar Pharmaceuticals$31.28-0.1%4.4394 of 5 stars2.25$50.33 60.9%41.75%GERNGeron$2.58-2.1%3.015 of 5 stars3.08$6.91 168.3%12Analyst ForecastAnalyst RevisionNews Coverage This page (NYSEARCA:PJP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.